SPL 1.04% 9.7¢ starpharma holdings limited

Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-128

  1. 3,347 Posts.
    lightbulb Created with Sketch. 792
    What part of the CEO saying ‘this is a new asset and not based on something that Starpharma has been working on in the past’ did you not understand?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.